Stock Events

Stock Events

Atrium Therapeutics (RNA) Q3 2025 Earnings

7AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-1.21

-1.02

-0.84

-0.65

Details

Expected EPS

-0.958163

Actual EPS

-1.21

Surprise EPS

-0.25

Surprise Percent

+26.28%

Description

Atrium Therapeutics (RNA) has reported earnings of -1.21 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.